Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation

Journal of Infection

Volumn 45, Issue 1, 2002, Pages 32-38

  Lim, D S ^a   Bae, K G ^a   Jung, I S ^a   Kim, C H ^b   Yun, Y S ^a   Song, J Y ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GINSENG EXTRACT; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; POLYSACCHARIDE; REAGENT; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFECT; DRUG ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MACROPHAGE ACTIVATION; MEDICAL RESEARCH; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PHAGOCYTOSIS; SEPSIS; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; SURVIVAL;

PANAX GINSENG; STAPHYLOCOCCUS AUREUS;

EID: 0036665069     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.1007     Document Type: Article

References (28)

1. Murphy K, Haudek SB, Thompson M. Molecular biology of septic shock. New Horiz 1998; 6: 181-193.
2. Rangel-Frausto MS. The epidemiology of bacterial sepsis. Infect Dis Clin North Am 1999; 13: 299-312.
3. Limjoco CM, Youmans K. Reviewing the details of coding septicemia. J AHIMA 2000; 71: 79-80.
4. Van der Poll T, van Deventer JH. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 1999; 13: 413-426.
5. Michel P, Glauser MD. Pathophysiologic basis of sepsis: Considerations for future strategies of intervention. Crit Care Med 2000; 28: S4-S8.
6. Nilsson IM, Lee JC, Bremell T, Ryden C, Tarkowski A. The role of Staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun 1997; 65: 4216-4221.
7. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
8. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 1998; 42: 199-200.
9. Klimetzek V, Remold HG. The murine bone marrow macrophage, a sensitive indicator cell for murine migration inhibitory factor and a new method for their harvest. Cell Immunol 1980; 53: 257.
10. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J Immunol 1984; 68: 167-175.
11. Nordan PR. Measurement of human and murine IL-6. In: Coligan JE, (eds) Current Protocols in Immunology, 2nd edn. NY: Greene publishing and Wiley-Interscience, 1994, 6.6.1-6.6.5.
12. Yun YS, Lee YS, Jo SK. Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an Immunomodulator. Planta Med 1993; 59: 521-524.
13. Lee YS, Chung IS, Lee IR, Kim KH, Hong YS, Yun YS. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide Ginsan isolated from Partax ginseng. Anticancer Res 1997; 17: 323-332.
14. Kim KH, Lee YS, Jung IS, Park SY, Chung HY, Lee IR, Yun YS. Acidic polysaccharide from Panax ginseng, Ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 1998; 64: 110-115.
15. Matsuda H, Kubo M, Tani T, Kitagawa I, Mizuno M. Pharmacological study on Panax ginseng C.A. Meyer (XI) Protective effect of red ginseng on infection (2) On phagocytic activity of mouse reticuloendothelial system. Shoyakugaku Zasshi 1987; 41: 135-141.
16. Matsuda H, Hasegawa T, Kubo M. Pharmacological study on Panax ginseng C.A. Meyer. VII. Protective effect of red ginseng on infection (1) On phagocytic activity of mouse reticuloendotherial system. Yakugaku Zasshi 1985; 105: 948-954.
17. Park SH, Jo JS. The effects of Korean ginseng (Panax ginseng C.A. Meyer) extracts and their fractions on the growth of Escherichia coli. Korean J Ginseng Sci 1993; 17: 203-209.
18. Walley KR, Lukacs NW, Standiford TJ. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996; 64: 4733-4738.
19. Zhao YX, Abdelnour A, Kalland T, Tarkowski A. Overexpression of the T-cell receptor Vβ3 in transgenic mice increase mortality during infection by enterotoxin A-producing Staphylococcus aureus. Infect Immun 1995; 63: 4463-4469.
20. Cohen J. Meningococcal disease as a model to evaluate novel antisepsis strategies. Crit Care Med 2000; 28: S64-S67.
21. Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CGM, Cohen Tervaert JW. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 2000; 26: 883-892.
22. Corradin SB, Buchmuller-Rouiller YB, Mauel J. Phagocytosis enhances routine macrophages activation by interferon-γ and tumor necrosis factor-α. Eur J Immunol 1991; 21: 2553-2558.
23. Fortier AH, Polsinelli T, Green SJ, Nacy CA. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells and effector molecules. Infect Immun 1992; 60: 817-825.
24. Malawista SE, Montgomery RR, van Blaricom G. Evidence of reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. J Clin Invest 1992; 90: 631-636.
25. Denis M. Tumor necrosis factor and granulocyte-macrophage colony-stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leuko Biol 1991; 49: 380-387.
26. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, Mcdaniel ML, Unanue ER. Release of nitric oxide during the T-cell-independent pathway of macrophage function: its role in resistance to Listeria monocytogenes. J Immunol 1993; 150: 888-895.
27. Green SJ, Nacy CA. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Cur Opin Infect Dis 1993; 6: 384-396.
28. Eizirik E. Nitric oxide synthase and antimicrobial armature of human macrophages. J Infect Dis 1994; 170: 744-745.